Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.300
-0.530 (-10.97%)
Oct 8, 2026, 3:55 PM HKT

HKG:2563 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-103.99-131.44-143.78-189.64-160.51-278.14
Depreciation & Amortization
13.210.629.8110.5610.468.65
Other Amortization
---0.060.040.03
Asset Writedown & Restructuring Costs
2.412.41-0.2--0.08
Loss (Gain) From Sale of Investments
-11.87-11.87-16.3-9.1-10.85-22.39
Stock-Based Compensation
---44.480.74-
Provision & Write-off of Bad Debts
20.6520.650.29-1.281.210.38
Other Operating Activities
101.879.94-6.01-16.96-22.38245.59
Change in Accounts Receivable
-15.72-15.72-13.3325.22-6.9-20.92
Change in Inventory
-14.07-14.07-3.313.07-8.44-16.99
Change in Accounts Payable
-30.88-30.8851.743.3928.236.24
Change in Unearned Revenue
----0.71-1.53-1.3
Change in Other Net Operating Assets
8.838.838.51-19.7910.5-
Operating Cash Flow
-29.56-151.52-112.59-150.78-79.44-78.77
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.33-5.42-40.8-27.84-31.86-11.06
Sale (Purchase) of Intangibles
-----0.82-
Investment in Securities
-21.783.8478.6145.98-114.11121.93
Other Investing Activities
7.1311.115.6813.14-17.57
Investing Cash Flow
-17.989.5253.47131.28-146.79128.44

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----0.07-
Total Debt Issued
----0.07-
Short-Term Debt Repaid
----0.07--
Long-Term Debt Repaid
----1.01-1.13-1.08
Lease Payments
----1.01-1.13-1.08
Total Debt Repaid
----1.07-1.13-1.08
Net Debt Issued (Repaid)
----1.07-1.06-1.08
Issuance of Common Stock
--209.71--0.27
Other Financing Activities
-1.25-1.25-1.6-0.064.59-
Financing Cash Flow
-1.25-1.25208.11-1.133.53-0.81

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.94-5.272.64-1.3914.38-4.9
Net Cash Flow
-51.65-68.52151.63-22.02-208.3143.96

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-32.89-156.94-153.39-178.62-111.3-89.83
Free Cash Flow Growth
------
Free Cash Flow Margin
-59.57%-470.38%-213.45%-268.05%-339.12%-126.41%
Free Cash Flow Per Share
-0.09-0.43-0.44-0.51-0.32-0.26
Levered Free Cash Flow
-9.03-77.99-162.66-99.06-46.5423.12
Unlevered Free Cash Flow
-9-77.96-162.62-99.03-46.4923.16
Free Cash Flow After Leases
-32.89-156.94-153.39-179.62-112.43-90.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.050.050.060.060.07-
Cash Income Tax Paid
-----1.08
Change in Working Capital
-51.83-51.8343.6111.1821.85-32.97